Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Medidata Solutions Inc    MDSO

MEDIDATA SOLUTIONS INC (MDSO)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Medidata Solutions Inc : Medidata Solutions Announces Two-for-One Stock Split

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/11/2013 | 12:31pm CET

Medidata Solutions (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that its Board of Directors approved a two-for-one (2:1) split of the Company's common stock at a regularly scheduled board meeting on November 7, 2013. The stock split will be structured in the form of a stock dividend.

The record date for the stock split is December 2, 2013. Shareholders of record as of such date will receive one new share of common stock for each share that they own. The distribution of the new shares will be made on December 16, 2013, and trading on a split-adjusted basis is expected to begin on or about December 17, 2013.

Medidata had approximately 26.8 million shares of common stock outstanding as of November 7, 2013. The stock split will increase the common shares outstanding to approximately 53.6 million.

About Medidata Solutions

Medidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud TM brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of our global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.

Investors:
Medidata Solutions
Hulus Alpay, 212-419-1025
[email protected]
or
Media:
Medidata Solutions
Gail Janowitz, 212-918-1792
[email protected]


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDIDATA SOLUTIONS INC
02/15MEDIDATA : and eClinical Solutions LLC Mark 10-Year Anniversary Milestone With E..
BU
02/14MEDIDATA : Named One of 100 Most Sustainable Companies in the U.S. by Barron's M..
BU
02/14MEDIDATA : Introduces New Edge Family of Products for Clinical Operations at SCO..
AQ
02/13MEDIDATA : Introduces New Edge Family of Products for Clinical Operations at SCO..
BU
02/12MEDIDATA SOLUTIONS : to Host Annual European NEXT Conference Series
BU
02/09GLOBAL CLINICAL TRIAL MANAGEMENT SYS : Clinical Trial Management System Market b..
AQ
02/08MEDIDATA SOLUTIONS (NASDAQ : MDSO) reported earnings of $0.41 per share beating ..
AQ
02/08MEDIDATA : beats Street 4Q forecasts
AQ
02/08MEDIDATA SOLUTIONS, INC. : Results of Operations and Financial Condition, Financ..
AQ
02/08MEDIDATA : Ushers in Era of Choice as Life Science Companies Can Now Conduct Bot..
BU
More news
News from SeekingAlpha
02/08Medidata Solutions (MDSO) Q4 2017 Results - Earnings Call Transcript 
02/08Medidata Solutions beats by $0.10, beats on revenue 
02/07Notable earnings before Thursday?s open 
01/02GETTING READY FOR 2018 : Results Of The 'Tip Of The Day' Series And How All The .. 
2017Deutsche Bank initiates Medidata 
Financials ($)
Sales 2018 637 M
EBIT 2018 125 M
Net income 2018 45,6 M
Finance 2018 153 M
Yield 2018 -
P/E ratio 2018 90,91
P/E ratio 2019 61,73
EV / Sales 2018 6,00x
EV / Sales 2019 4,90x
Capitalization 3 974 M
Chart MEDIDATA SOLUTIONS INC
Duration : Period :
Medidata Solutions Inc Technical Analysis Chart | MDSO | US58471A1051 | 4-Traders
Technical analysis trends MEDIDATA SOLUTIONS INC
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 78,9 $
Spread / Average Target 16%
EPS Revisions
Managers
NameTitle
Tarek A. Sherif Chairman & Chief Executive Officer
Glen Michael de Vries President & Director
Rouven Bergmann Chief Financial & Accounting Officer
Julie Iskow Chief Technology Officer
Neil M. Kurtz Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MEDIDATA SOLUTIONS INC0.32%3 903
INTERNATIONAL BUSINESS MACHINES CORPORATION0.87%143 275
ACCENTURE4.38%103 253
TATA CONSULTANCY SERVICES8.22%87 677
VMWARE, INC.-0.72%50 158
AUTOMATIC DATA PROCESSING-3.82%49 961